Riociguat for the treatment of pulmonary hypertension in patients with end stage renal disease

The role of riociguat in combination therapies for pulmonary arterial hypertension

(2023) Franck F. Rahaghi et al.   RESPIRATORY MEDICINE

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

(2021) Aaron Waxman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vasodilator use in precapillary pulmonary hypertension with end stage kidney disease: A single center experience

(2021) Carlo Arevalo et al.   RESPIRATORY MEDICINE

Pulmonary hypertension in end-stage renal disease

(2020) Joe Devasahayam et al.   RESPIRATORY MEDICINE

Pulmonary Hypertension: A Brief Guide for Clinicians

(2020) Stacy A. Mandras et al.   MAYO CLINIC PROCEEDINGS

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN HEART JOURNAL

Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Riociguat for the Treatment of Pulmonary Arterial Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension

(2009) F. Grimminger et al.   EUROPEAN RESPIRATORY JOURNAL